Tuberculosis diagnostics trials: Do they lack methodological rigor?

Expert Review of Molecular Diagnostics

Volumn 6, Issue 4, 2006, Pages 509-514

  Pai, Madhukar ^a   O'Brien, Richard ^b  

^a MCGILL UNIVERSITY   (Canada)

^b FOUNDATION FOR INNOVATIVE NEW DIAGNOSTICS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

DIAGNOSTIC ACCURACY; DIAGNOSTIC APPROACH ROUTE; EDITORIAL; HEALTH CARE QUALITY; METHODOLOGY; MICROSCOPY; NUCLEIC ACID AMPLIFICATION; SYSTEMATIC ERROR; TUBERCULOSIS; TUBERCULOSIS CONTROL; WORLD HEALTH ORGANIZATION;

CLINICAL TRIALS; DEVELOPING COUNTRIES; HUMANS; QUALITY CONTROL; RESEARCH DESIGN; TUBERCULOSIS;

EID: 33746828213     PISSN: 14737159     EISSN: 17448352     Source Type: Journal    
DOI: 10.1586/14737159.6.4.509     Document Type: Editorial

References (40)

1. WHO. Global Tuberculosis Control. Surveillance, Planning, Financing. WHO Report 2006. WHO/HTM/TB/2006.362. WHO, Geneva, Switzerland 1-242 (2006).
2. Small PM, Perkins MD. More rigour needed in trials of new diagnostic agents for tuberculosis. Lancet 356(9235), 1048-1049 (2000).
3. Perkins MD, Roscigno G, Zumla A. Progress towards improved tuberculosis diagnostics for developing countries. Lancet 367(9514), 942-943 (2006).
4. Pai M, Kalantri S, Dheda K. New tools and emerging technologies for the diagnosis of tuberculosis: Part 1. Latent tuberculosis. Expert Rev. Mol. Diagn. 6(3), 413-422 (2006).
5. Pai M, Kalantri S, Dheda K. New tools and emerging technologies for the diagnosis of tuberculosis: Part 2. Active tuberculosis and drug resistance. Expert Rev. Mol. Diagn. 6(3), 423-432 (2006).
6. Walsh A, McNerney R. Guidelines for establishing trials of new tests to diagnose tuberculosis in endemic countries. Int. J. Tuberc. Lung Dis. 8(5), 609-613 (2004).
7. Whiting P, Rutjes AW, Reitsma JB et al. Sources of variation and bias in studies of diagnostic accuracy: a systematic review. Ann. Intern. Med. 140(3), 189-202 (2004).
8. Lijmer JG, Mol BW, Heisterkamp S et al. Empirical evidence of design-related bias in studies of diagnostic tests. JAMA 282(11), 1061-1066 (1999).
9. Whiting P, Rutjes AW, Reitsma JB, Bossuyt PM, Kleijnen J. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med. Res. Methodol. 3, 25 (2003).
10. Whiting PF, Weswood ME, Rutjes AW et al. Evaluation of QUADAS, a tool for the quality assessment of diagnostic accuracy studies. BMC Med. Res. Methodol. 6, 9 (2006).
11. Pai M, McCulloch M, Enanoria W, Colford JM Jr. Systematic reviews of diagnostic test evaluations: what's behind the scenes? ACP J. Club 141(1), A11-A13 (2004).
12. Sarmiento OL, Weigle KA, Alexander J, Weber DJ, Miller WC. Assessment by meta-analysis of PCR for diagnosis of smear-negative pulmonary tuberculosis. J. Clin. Microbiol. 41(7), 3233-3240 (2003).
13. Goto M, Noguchi Y, Koyama H et al. Diagnostic value of adenosine deaminase in tuberculous pleural effusion: a meta-analysis. Ann. Clin. Biochem. 40(Pt 4), 374-381 (2003).
14. Pai M, Flores LL, Pai N et al. Diagnostic accuracy of nucleic acid amplification tests for tuberculous meningitis: a systematic review and meta-analysis. Lancet Infect. Dis. 3(10), 633-643 (2003).
15. Greco S, Girardi E, Masciangelo R, Capoccetta GB, Saltini C. Adenosine deaminase and interferon γ measurements for the diagnosis of tuberculous pleurisy: a meta-analysis. Int. J. Tuberc. Lung Dis. 7(8), 777-786 (2003).
16. Pai M, Flores LL, Hubbard A, Riley LW, Colford JM Jr. Nucleic acid amplification tests in the diagnosis of tuberculous pleuritis: a systematic review and meta-analysis. BMC Infect. Dis. 4(1), 6 (2004).
17. Flores LL, Pai M, Colford JM Jr, Riley LW. In-house nucleic acid amplification tests for the detection of Mycobacterium tuberculosis in sputum specimens: meta-analysis and meta-regression. BMC Microbiol. 5, 55 (2005).
18. Kalantri S, Pai M, Pascopella L, Riley L, Reingold A. Bacteriophage-based tests for the detection of Mycobacterium tuberculosis in clinical specimens: a systematic review and meta-analysis. BMC Infect. Dis. 5(1), 59 (2005).
19. Pai M, Kalantri S, Pascopella L, Riley LW, Reingold AL. Bacteriophage-based assays for the rapid detection of rifampicin resistance in Mycobacterium tuberculosis: a meta-analysis. J. Infect. 51(3), 175-187 (2005).
20. Morgan M, Kalantri S, Flores L, Pai M. A commercial line probe assay for the rapid detection of rifampicin resistance in Mycobacterium tuberculosis: a systematic review and meta-analysis. BMC Infect. Dis. 5, 62 (2005).
21. Greco S, Girardi E, Navarra S, Saltini C. The current evidence on diagnostic accuracy of commercial based nucleic acid amplification tests for the diagnosis of pulmonary tuberculosis. Thorax (2006) (In Press).
22. Steingart K, Henry M, Ng V et al. Fluorescence versus conventional sputum smear microscopy for tuberculosis: a systematic review. Presented at: 10th Annual Conference of the International Union Against Tuberculosis and Lung Disease (North American Region). IL, USA, March 2-4 (2006).
23. Steingart KR, Ng V, Henry MC et al. Sputum processing methods to improve the sensitivity of smear microscopy for tuberculosis: a systematic review. Presented at: 10th Annual Conference of the International Union Against Tuberculosis and Lung Disease (North American Region). IL, USA, March 2-4 (2006).
24. Rutjes AW, Reitsma JB, Di Nisio M et al. Evidence of bias and variation in diagnostic accuracy studies. CMAJ 174(4), 469-476 (2006).
25. Rutjes AW, Reitsma JB, Vandenbroucke JP, Glas AS, Bossuyt PM. Case-control and twogate designs in diagnostic accuracy studies. Clin. Chem. 51(8), 1335-1341 (2005).
26. Marais BJ, Gie RP, Schaaf HS et al. Childhood pulmonary tuberculosis: old wisdom and new challenges. Am. J. Respir. Crit. Care Med. 173(10), 1078-1090 (2006).
27. Hadgu A, Dendukuri N, Hilden J. Evaluation of nucleic acid amplification tests in the absence of a perfect gold-standard test: a review of the statistical and epidemiologic issues. Epidemiology 16(5), 604-612 (2005).
28. Pai M, Riley LW, Colford JM Jr. Interferon-γ assays in the immunodiagnosis of tuberculosis: a systematic review. Lancet Infect. Dis. 4(12), 761-776 (2004).
29. Bossuyt PM, Reitsma JB, Bruns DE et al. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD Initiative. Ann. Intern. Med. 138(1), 40-44 (2003).
30. Pai M, Flores LL, Hubbard A, Riley LW, Colford JM Jr. Quality assessment in meta-analyses of diagnostic studies: what difference does email contact with authors make? Presented at: The XI Cochrane Colloquium, Barcelona, Spain, October 26-31 (2003).
31. WHO: Stop TB Department www.who.int/tb
32. Global Plan to Stop TB 2006-2015 www.stoptb.org/globalplan
33. Stop TB Partnership www.stoptb.org
34. UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases www.who.int/tdr
35. ICH Harmonised Tripartite Guideline: Guideline For Good Clinical Practice E6(R1) www.ich.org/LOB/media/MEDIA482.pdf
36. Good Clinical Laboratory Practice www.barqa.com/cms.php?pageid=645
37. American Thoracic Society www.thoracic.org
38. International Union Against Tuberculosis and Lung Disease www.iuatld.org
39. Stop TB Strategy www.who.int/tb/features_archive/stop_tb_strategy/en/ index.html
40. Foundation for Innovative New Diagnostics www.finddiagnostics.org